Followers | 27 |
Posts | 1054 |
Boards Moderated | 0 |
Alias Born | 11/05/2020 |
Monday, April 22, 2024 3:37:17 PM
But Feldenkrais is a terrible business person with a sprinkle of shadiness thrown in. And, yes, I suppose he did deceive fluent with a few sleight of hands about his "operation." And the shareholders as well.
I don't think Feldenkrais scammed us. But I do think he fraudulently held himself out to be something it wasn't with Fluent. And he got busted for it.
I really believe that Fluent has the stronger position here. I want my money back but I would like to see Fluent win.
(1) Paragraph 4 in the Service Agreement states:Compensation and Terms: The contractor shall be paid for it's services on a per plant output basis. Output means produced. CIGN never produced a single, sell-able plant. How can you charge someone when nothing was ever produced?
(2) Contamination at the facility predates when Fluent was there. There is proof of COA's that have heavy metals in them from the hemp grown by Feldenkrais.
(3) Fluent was never truly in compliance with the Department of Health. The mortgage company prohibited the use of the facility as a medical marijuana grow operation. The contract with CIGN and the mortgage company would have made Fluent not in compliance for the growing of the plants. Fluent's lease agreement with CIGN should be voided as two lease agreements were in effect at the same time.
(4) Fluent CEO stated that he believed the hemp products he tested at the homestead facility were made from the hemp grown on site. He later learned that was not true. I believe him when he says this. I believe Feldenkrais used a sleight of hand to convince Fluent to use their facility.
Recent CATV News
- Progress Report February 13 2024 • InvestorsHub NewsWire • 02/13/2024 04:25:04 PM
- Letter to Shareholders from 4Cable TV International, Inc. • InvestorsHub NewsWire • 01/05/2024 02:00:00 PM
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM